Arog Pharmaceuticals, Inc. - FORM S-1 - EX-23.1 - EXHIBIT 23.1 - September 28, 2018

Attached files

file filename
EX-10.10 - EXHIBIT 10.10 - Arog Pharmaceuticals, Inc.dp96164_ex1010.htm
EX-99.4 - EXHIBIT 99.4 - Arog Pharmaceuticals, Inc.dp96164_ex9904.htm
EX-99.3 - EXHIBIT 99.3 - Arog Pharmaceuticals, Inc.dp96164_ex9903.htm
EX-99.2 - EXHIBIT 99.2 - Arog Pharmaceuticals, Inc.dp96164_ex9902.htm
EX-99.1 - EXHIBIT 99.1 - Arog Pharmaceuticals, Inc.dp96164_ex9901.htm
EX-10.17 - EXHIBIT 10.17 - Arog Pharmaceuticals, Inc.dp96164_ex1017.htm
EX-10.16 - EXHIBIT 10.16 - Arog Pharmaceuticals, Inc.dp96164_ex1016.htm
EX-10.15 - EXHIBIT 10.15 - Arog Pharmaceuticals, Inc.dp96164_ex1015.htm
EX-10.14 - EXHIBIT 10.14 - Arog Pharmaceuticals, Inc.dp96164_ex1014.htm
EX-10.13 - EXHIBIT 10.13 - Arog Pharmaceuticals, Inc.dp96164_ex1013.htm
EX-10.12 - EXHIBIT 10.12 - Arog Pharmaceuticals, Inc.dp96164_ex1012.htm
EX-10.11 - EXHIBIT 10.11 - Arog Pharmaceuticals, Inc.dp96164_ex1011.htm
EX-10.9 - EXHIBIT 10.9 - Arog Pharmaceuticals, Inc.dp96164_ex1009.htm
EX-10.8 - EXHIBIT 10.8 - Arog Pharmaceuticals, Inc.dp96164_ex1008.htm
EX-10.6 - EXHIBIT 10.6 - Arog Pharmaceuticals, Inc.dp96164_ex1006.htm
EX-10.4 - EXHIBIT 10.4 - Arog Pharmaceuticals, Inc.dp96164_ex1004.htm
EX-3.2 - EXHIBIT 3.2 - Arog Pharmaceuticals, Inc.dp96164_ex0302.htm
EX-3.1 - EXHIBIT 3.1 - Arog Pharmaceuticals, Inc.dp96164_ex0301.htm
S-1 - FORM S-1 - Arog Pharmaceuticals, Inc.dp96164_s1.htm

Exhibit 23.1

 

 

Consent of Independent Registered Public Accounting Firm

 

We have issued our report dated June 22, 2018, with respect to the financial statements of Arog Pharmaceuticals, Inc. contained in the Registration Statement and Prospectus. We consent to the use of the aforementioned report in the Registration Statement and Prospectus, and to the use of our name as it appears under the caption “Experts”.

 

 

/s/ GRANT THORNTON LLP

 

Dallas, Texas

September 28, 2018